Zum Inhalt springen

Nur-Lesen-Fassung: Das Forschungsinformationssystem (FIS) ist aus Sicherheitsgründen vorübergehend durch diese Nur-Lesen-Fassung ersetzt. Alle öffentlichen Inhalte und Volltexte sind weiterhin abrufbar; Anmeldung, Bearbeitung, Einreichung und Statistiken stehen nicht zur Verfügung. Bei Fragen: fis@uni-bamberg.de

Start › Publikationen › Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study

Publikation

Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study

Schmitt, Andreas; Reimer, André; Ehrmann, Dominic; u. a. (2017): Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study, in: Journal of Diabetes and its Complications, Amsterdam: Elsevier, Jg. 31, Nr. 11, S. 1608–1613, doi: 10.1016/j.jdiacomp.2017.08.004.

Details

Fakultät/Lehrstuhl
Autorin(nen)/Autor(en)
Schmitt, Andreas
Reimer, André
Haak, Thomas
Titel der Zeitschrift
Journal of Diabetes and its Complications
ISSN
1056-8727
Verlagsangabe
Elsevier : Amsterdam
Erscheinungsjahr
2017
Jahrgang
31
Heft
11
Sprache(n)
Englisch
DOI
Abstract

Aims: Evidence from randomised trials analysing effects of depression treatment on glycaemic control in group comparisons is inconsistent. The aim of this study was to test if the reduction of depressive symptoms would explain improved glycaemic control irrespective of treatment groups.

Methods: The DIAMOS study tested effects of cognitive-behavioural therapy (CBT) versus usual care on depressive symptoms in a 12-month prospective trial; HbA1c was a secondary outcome. Since the results suggested superiority of CBT for improving depressive symptoms, but not HbA1c, we conducted this secondary analysis to test if reduction of depressive symptoms could explain improved glycaemic control when assessed irrespective of treatment group affiliation. Reduction of depressive symptoms was assessed using baseline-to-follow-up changes in the Center for Epidemiologic Studies Depression Scale (CES-D). We used multiple regression analyses, adjusting for baseline HbA1c and depression, group affiliation and covariates, to assess associations between reduction of depressive symptoms and follow-up HbA1c.

Results: 181 participants provided eligible data. Depressive symptoms decreased between baseline and follow-up by averagely − 5.1 ± 11.8 CES-D points. Greater reduction of depressive symptoms predicted greater improvement of HbA1c at follow-up, while adjusting for baseline HbA1c and covariates (Beta = − 0.24, P = 0.004). Additionally, patients with greater reduction of depressive symptoms were more likely to reach in-target HbA1c (< 7.5%) at follow-up (adjusted OR = 1.04, 95% CI 1.01–1.08, P = 0.023).

Conclusions: The findings suggest that reduction of depressive symptoms can explain improved glycaemic control. Behavioural treatments might aim to improve both affective and glycaemic outcomes.

Freie Schlagwort(e)
Depression
Affective disorder
Mood
HbA1c
Metabolic control
Peer Reviewed
ja
Internationale Verbreitung
ja
Open-Access-Zeitschrift
nein
Dokumenttyp
Artikel in einer Zeitschrift / Postprint
URI
Datum der Freischaltung
22.06.2018, 22.06.2018

Permalink: https://fis.uni-bamberg.de/handle/uniba/43932 · Daten als JSON · Zitieren: BibTeX · RIS

Datenstand: 16.11.2026

Eingeschränkter Lesezugriff: Anmeldung, Bearbeitung und Einreichung sind vorübergehend deaktiviert.